Team

John A. St. Cyr, MD, PhD, a retired cardiovascular surgeon, received his B.A., B.S., M.S., M.D., and Ph.D. degrees from the University of Minnesota, Minneapolis, MN. He completed his General Surgical Training at the University of Minnesota and completed his Cardiovascular Surgical Fellowship Training at the University of Colorado Health Sciences Center in Denver, CO.

Dr. St.Cyr has extensive research credentials, is widely published, has received numerous local and national research grants, has numerous patents in various fields of interest, and has presented at both national and international meetings. Currently, Dr. St. Cyr has 18 issued patents, 16 patents pending, and numerous provisional patent submissions. Dr. St. Cyr has consulted for many medical companies, such as a surgical/medical consultant for Medtronic, Inc. (Physiological Research Laboratories, a facility of Medtronic, Inc., Minneapolis, MN), a medical/surgical consultant for NAMSA/Integra, Inc. (Minneapolis, MN), surgical consultant for NeoCardial, Inc. (Minneapolis, MN), Chief Medical Officer for RCRI, Inc. (Minneapolis, MN), ImmuMeds, Inc. (Minneapolis, MN) Time Savers Technologies (Minneapolis, MN) and Nuvaira, Inc. (Minneapolis, MN). Dr. St. Cyr is a member of many Editorial Boards, as well as a member of the Board of Directors for medical device companies. 

Dr. St. Cyr is a member of numerous scientific research, medical, and surgical societies. His current interests center on applications for Heart failure, Myocardial ischemia and diastolic dysfunction, applications for Atrial fibrillation, medical/surgical applications of D-ribose, Blood storage, Dialysis, and Immune modulation. 

Donald B. Wingerter 

From December 2009 through January 2012, Mr. Wingerter served as chief executive officer of Ampio Pharmaceuticals, Inc., a development stage pharmaceutical company, and served as a member of the Board of Directors of Ampio from March 2010 through January 2012. Ampio is a public company (Nasdaq Capital Market: AMPE) that develops innovative proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation, CNS disease, and male sexual dysfunction, with a product pipeline including new uses for previously approved drugs and new molecular entities. While Mr. Wingerter was with Ampio, its market capitalization increased from approximately $17 million to over $200 million, making Ampio the fastest growing company by market capitalization in the Russell 3000 index for the first nine months of 2011. 


From 2006 until 2012, Mr. Wingerter has served as a member of the board of directors of several private companies in which he holds personal investments. From June 2002 until 2006, Mr. Wingerter was the chief executive officer of Sound Surgical Technologies, Inc., a specialty medical device company that developed and marketed proprietary ultrasonic-based products to break up and remove fat deposits from the human body. 


From 1995 to 2001, Mr. Wingerter was engaged in managing his personal investments, prior to which, Mr. Wingerter was chairman of the board and chief executive officer of ClearVision Laser Centers, a company he founded in 1995 that operated centers providing laser vision correction services to consumers. ClearVision had operations in 14 states consisting of 10 centers utilizing fixed excimer lasers and 42 centers serviced by mobile lasers. In 2001, ClearVision was sold to  two private equity firms providing investors with an approximate 12 fold return.


Before founding ClearVision, Mr. Wingerter served as chief executive officer and president, respectively, of Western Imaging Technologies and Accel Holdings, medical imaging companies that sold and leased magnetic resonance imaging (MRI), positron emission tomography (PET), and computer tomography (CT) imaging equipment. He also spent 11 years in various sales positions with General Electric Medical Systems, the last of which was National Sales Manager for Digital Products. Mr. Wingerter holds a B.S. degree in biology from Lafayette College and a M.S. degree in physiology from Rutgers University.

Lynn Ramsey is a visionary leader with an unparalleled blend of business expertise and a passion for healthy living. As the newly appointed President of Jacqmar, Inc., a well- established Minnesota company, Lynn brings a wealth of experience and an inspiring track record of success.

With a remarkable career spanning over three decades, Lynn's journey is a testament to her tenacity and exceptional leadership skills. Having owned her own thriving service company for over 30 years, she understands the current dynamics and future potential aspects in the business landscape. Her keen insights and innovative strategies have driven her company to flourish, making her a respected name in the industry.

Beyond her business acumen, Lynn is a fierce advocate of healthy living. Having navigated her own health issues with determination, she has become an unwavering champion for proper nutrition and holistic well-being. Her personal journey has equipped her with a deep understanding of the transformative power of healthy habits, and she is determined to continue and foster the culture of wellness within Jacqmar.

Being on the board of the regional association of her business' industry, Lynn continues to empower others in her field and advocates for positive change. Her forward-thinking approach and unwavering dedication make her the ideal catalyst for Jacqmar’s continued growth and innovation.

Under Lynn's astute leadership, Jacqmar Inc. is poised for an era of unprecedented growth, product development and financial success. Her ability to create a synergy in business excellence with a passion for healthy living will undoubtedly propel Jacqmar Inc. to new heights, setting new industry standards along the way.

Landon Ramsey studied business management at the University of North Dakota and has a strong background in management and exhibits constant leadership skills in all endeavors. Landon has used these skills most effectively in returning from college and accepting the operational manager role of a very prosperous 52-year old family business, in which he continues to play a pivotal role in the growth and innovation.

The success of a company depends on the technology (product), but of equal importance is the personnel of the company. This is paramount for start-up companies that rely on strong leaders and visionary individuals for growth and success. Landon Ramsey is such an individual. Landon possesses strong business qualifications, intelligence, corporate and thought driven, dedication to success, and is a visionary. He is exceptionally a strong leader and possesses a keen sense of assessing a situation and thereafter designing a “game plan”, leading to a successful outcome. Landon sees opportunities and uses his skills to make it happen. Jacqmar, Inc. is fortunate to have Landon as their Vice President and Secretary.

A major division in Jacqmar, Inc. centers on developing products that contain D-ribose, a natural occurring carbohydrate, which has shown to be a key factor in rapidly replenishing cellular energy levels at times of stress, such as in high intensity exercise, as well as in medical conditions. Landon, being a marathon runner and avid health advocate, has enjoyed promoting the benefits of D-ribose during his training and competing and continues to explore it. Landon’s role in Jacqmar can’t be stated enough, he brings an enriched attitude and corporate drive, intelligence, excellent management and leadership skills that any company would embrace.